8-KItem 7.01 · Reg FD DisclosureItem 9.01 · Financial Statements
Bristol-Myers Squibb ($BMY) filed a Form 8‑K on Jan 12, 2026 furnishing an investor presentation (Exhibit…
Filed with the SEC on · Summarized by InvestorsBot
Bristol-Myers Squibb ($BMY) filed a Form 8‑K on Jan 12, 2026 furnishing an investor presentation (Exhibit 99.1) dated Jan 12, 2026 and an Inline XBRL cover page (Exhibit 104). 📄📅 #8K #pharma
Investors: Exhibit 99.1 (investor presentation) has been furnished — review for company updates and strategy. The 8‑K lists only Exhibits 99.1 and 104; no other agreements or financials attached. 🔍 $BMY #InvestorDeck #8K
The report was signed Jan 12, 2026 by Amy Fallone, SVP & Corporate Secretary. Access the filing and investor deck on SEC EDGAR to assess potential impacts on outlook. 🖊️ $BMY #SECfiling #investing